Bicycle Therapeutics plc (BCYC) ADS REP 1 SHS SPON

Sell:$22.50Buy:$22.55$0.14 (0.62%)

NASDAQ:0.64%
Market closed | Prices delayed by at least 15 minutes
Sell:$22.50
Buy:$22.55
Change:$0.14 (0.62%)
Market closed | Prices delayed by at least 15 minutes
Sell:$22.50
Buy:$22.55
Change:$0.14 (0.62%)
Market closed | Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
11 April 2024
Michael Charles Ferguson (Mike) HannayChief Level Officer
Sell
Tax related
257$22.49$5,779.9322,891
3 April 2024
Kevin LeeCEO
Sell
Tax related
3,158$23.81$75,191.98387,270
3 April 2024
Michael SkynnerCTO
Sell
Tax related
955$23.81$22,738.5594,884
3 April 2024
Alistair MilnesCOO
Sell
Tax related
955$23.81$22,738.5572,241
3 April 2024
Nicholas (Nick) KeenChief Level Officer
Sell
Tax related
790$23.81$18,809.9062,803
3 April 2024
Nigel CrockettChief Level Officer
Sell
Tax related
955$23.81$22,738.5547,761
3 April 2024
Travis Alvin ThompsonChief Accounting Officer
Sell
Tax related
152$23.81$3,619.1223,223
3 January 2024
Kevin LeeCEO
Sell
Tax related
8,703$17.50$152,302.50390,428
3 January 2024
Michael SkynnerCTO
Sell
Tax related
2,643$17.50$46,252.5095,839
3 January 2024
Alistair MilnesCOO
Sell
Tax related
2,643$17.50$46,252.5073,196

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
17 July 2023
BAKER BROS ADVISORS LPHedge Fund
Buy
Regular purchase transaction
4,342,429$21.25$92,276,616.254,342,429
17 July 2023
BAKER BROS ADVISORS LPHedge Fund
Buy
Regular purchase transaction
363,453$21.25$7,723,376.25363,453
3 January 2024
Kevin LeeCEO
Sell
Tax related
8,703$17.50$152,302.50390,428
3 April 2024
Kevin LeeCEO
Sell
Tax related
3,158$23.81$75,191.98387,270
3 January 2024
Michael SkynnerCTO
Sell
Tax related
2,643$17.50$46,252.5095,839

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.